Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Recruiting now · Phase 1/Phase 2

Conditions studied: Tumors Metastatic to Brain

In brief

This Phase I/II trial studies the ability to stop brain metastases from coming back after treatment with radiosurgery followed by surgical resection. It will also evaluate the side effects of these combined treatments and help determine the best radiosurgery dose. Radiosurgery focuses the x-rays directly to the tumor and cause less damage to the normal tissue in the brain.

Key facts

Study ID
NCT01891318
Run by
Case Comprehensive Cancer Center
People needed
36
Starts
2013-07-03
Expected to finish
2026-09-01
Last updated by the study team
2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.